Mikrogen
Protagen, Mikrogen Ink Lyme Disease Diagnostic Deal
The companies are co-developing an assay that differentiates previously infected, seropositive Lyme disease patients from newly infected individuals.
The company has signed an agreement with biopharmaceutical firm SuppreMol to use its UNIarray technology to identify autoantibody signatures of SLE patients enrolled in a phase IIa study of SuppreMol's lead therapeutic SM101.
Progen Biotechnik Inks Deals for Assay Distribution, Development
In separate deals announced this past week, the German biotech firm will distribute assays developed by Asuragen, and co-develop, co-manufacture, and co-market assays with Mikrogen.
Protagen Employs UNIarray Platform to Detect Protein Biomarkers Associated with Infectious Disease
Premium
The company is collaborating with fellow German biotech firm Mikrogen to identify autoantibody signatures typical of various infectious diseases.
Jul 6, 2010
Jul 6, 2010